Investors of Inspire Medical Systems Urged to Act Before January 5, 2026 Following Allegations
Investors Alert: Inspire Medical Systems Securities Class Action
Investors in Inspire Medical Systems, Inc. (NYSE: INSP) are urged to reach out to Levi & Korsinsky, LLP as they may have rights under current legal proceedings related to alleged securities fraud. This advisory is crucial for those who suffered losses between August 6, 2024, and August 4, 2025, due to the company’s failures regarding the launch of their new product, Inspire V.
Background
On December 16, 2025, it was announced that a class action had been filed against Inspire Medical Systems. The case is founded on serious allegations of false statements made by the company regarding the performance and launch of its new product. According to the complaint, defendants misled investors about the demand for Inspire V and the company’s operational readiness for the product launch.
Reports indicate that healthcare providers possessed substantial amounts of excess inventory of Inspire V, creating hesitance in transitioning to the new treatment. Moreover, it was alleged that Inspire Medical failed to complete several key steps necessary for a successful launch, including training for treatment centers, IT system setups, and ensuring Medicare reimbursement availability. This lack of preparation contradicted earlier assurances given to investors that preparations were made for a successful market entry.
The Next Steps for Investors
If you are an investor who experienced financial losses during the specified timeframe, it is imperative to act quickly. You have until January 5, 2026, to initiate action by contacting Levi & Korsinsky to potentially be appointed as the lead plaintiff in the class action. It is important to note that you do not have to serve as lead plaintiff to be eligible for any recovery; participation is accessible for all affected investors.
Levi & Korsinsky operates on a no-cost basis for class members, meaning you may qualify for compensation without any out-of-pocket expenses. Given their extensive experience—having secured hundreds of millions for aggrieved shareholders as acknowledged in ISS Securities Class Action Services' Top 50 Report—this firm boasts a robust record in managing complex securities litigation.
Contact Information
- - Joseph E. Levi, Esq.
Phone: (212) 363-7500
- - Address: Levi & Korsinsky, LLP
New York, NY 10004
For more details on the class action lawsuit, visit the following link: Inspire Medical Systems Class Action Information.
Conclusion
With significant implications for investors in Inspire Medical Systems, it is crucial to take immediate action if you belong to the affected group. Understanding your rights and the legal avenues available can potentially pave the way for recovery from the financial losses endured during the tumultuous product launch period. Don’t hesitate to reach out to Levi & Korsinsky to discuss your situation and next steps.
Topics Financial Services & Investing）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.